CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today financial results for the second quarter and six months ended June 30, 2008 and provided guidance for clinical milestones through the first half of 2009.
